Compositions and methods comprising anti-nrp2 antibodies
US-2026092122-A1 · Apr 2, 2026 · US
This page is not indexed by search engines while we improve data quality.
Atyr Pharma Inc — Human Necessities
Atyr Pharma Inc holds 168 patents in Human Necessities, with representative filings summarized below.
| Metric | Value |
|---|---|
| Company | Atyr Pharma Inc |
| Technology | Human Necessities |
| Patents in slice | 168 |
| Recent patents in slice | 12 |
| First year | 2015 |
| Last year | 2026 |
Representative patents
Notable publications linking Atyr Pharma Inc to Human Necessities.
Compositions and methods comprising anti-nrp2 antibodies
US-2026092122-A1 · Apr 2, 2026 · US
Compositions and methods comprising anti-nrp2 antibodies
US-2026092122-A1 · Apr 2, 2026 · US
Compositions and methods comprising anti-nrp2 antibodies
US-2026092122-A1 · Apr 2, 2026 · US
Compositions and methods comprising anti-nrp2 antibodies
US-2026092122-A1 · Apr 2, 2026 · US
Recent filings
Latest patents from Atyr Pharma Inc in Human Necessities.
Compositions and methods comprising anti-nrp2 antibodies
US-2026092122-A1 · Apr 2, 2026 · US
Compositions and methods comprising anti-nrp2 antibodies
US-2026092122-A1 · Apr 2, 2026 · US
Compositions and methods comprising anti-nrp2 antibodies
US-2026092122-A1 · Apr 2, 2026 · US
Compositions and methods comprising anti-nrp2 antibodies
US-2026092122-A1 · Apr 2, 2026 · US
Compositions and methods comprising anti-nrp2 antibodies
US-2026092122-A1 · Apr 2, 2026 · US
Related pages
Navigate to parent entity pages.